Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 2/20 | 0.48 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.44 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.39 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22122724 | 0.85 | PNMT (0.46) | PNMTPPARGPPARAMAPTMAPK1 | |
| SCHEMBL22122819 | 0.85 | PNMT (0.46) | PNMTGABRA1GABRB2PPARGPPARA | |
| SCHEMBL22122818 | 0.85 | PNMT (0.46) | PNMTGABRA1GABRB2PPARGPPARA | |
| SCHEMBL16649712 | 0.85 | PNMT (0.70) | PNMTSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL22145308 | 0.85 | PNMT (0.46) | PNMTGABRA1GABRB2PPARGPPARA | |
| SCHEMBL6126362 | 0.84 | PNMT (0.48) | PNMTGABRA1GABRB2AKR1C2AKR1C1 | |
| SCHEMBL24568964 | 0.83 | PNMT (0.44) | PNMTPPARGPPARAMAPTMAPK1 | |
| SCHEMBL2623873 | 0.81 | GABRA1 (0.48) | GABRA1GABRB2AKR1C2PPARGMAPT | |
| SCHEMBL9176216 | 0.81 | GABRA1 (0.48) | GABRA1GABRB2AKR1C2PPARGMAPT | |
| SCHEMBL5018935 | 0.81 | PNMT (0.70) | PNMTGABRA1GABRB2AKR1C2AKR1C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024105159-A1 | LIGANDS OF THE M6A-RNA READERS | UNIVERSITY OF ZURICH (CH) | 2024-05-23 | — | — | WO | disclosed |
| US-20230303562-A1 | PYRAZOLE COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) | 2023-09-28 | — | — | US | disclosed |
| US-20230303562-A1 | PYRAZOLE COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) | 2023-09-28 | — | — | US | disclosed |
| US-20220204565-A1 | Cyclic Peptide Antiviral Agents and Methods Using Same | UNIV DREXEL (US) | 2022-06-30 | — | — | US | disclosed |
| US-20220095614-A1 | Antibiotic Compounds | THE GENERAL HOSPITAL CORPORATION | 2022-03-31 | — | — | US | disclosed |
| US-20210047329-A1 | SUBSTITUTED 4,6-DIHYDROSPIRO[[1,2,3]TRIAZOLO[4,5-B]PYRIDINE-7,3'-INDOLINE]-2',5(3H)-DIONE ANALOGUES | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2021-02-18 | — | — | US | disclosed |
| US-20200190009-A1 | Antibiotic Compounds | TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2020-06-18 | — | — | US | disclosed |
| US-20190375792-A1 | Cyclic Peptide Antiviral Agents and Methods Using Same | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2019-12-12 | — | — | US | disclosed |
| US-20190084988-A1 | WDR5 INHIBITORS AND MODULATORS | VANDERBILT UNIVERSITY | 2019-03-21 | — | — | US | disclosed |
| US-20180086767-A1 | WDR5 INHIBITORS AND MODULATORS | VANDERBILT UNIVERSITY | 2018-03-29 | — | — | US | disclosed |
| US-20180086767-A1 | WDR5 INHIBITORS AND MODULATORS | VANDERBILT UNIVERSITY | 2018-03-29 | — | — | US | disclosed |
| US-9492460-B2 | Carbazole compounds useful as bromodomain inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-11-15 | — | — | US | disclosed |
| US-20140256700-A1 | CARBAZOLE COMPOUNDS USEFUL AS BROMODOMAIN INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2014-09-11 | — | — | US | disclosed |
| WO-2012014908-A1 | METHOD FOR SYNTHESIZING DIKETOPYRACENE | CANON KABUSHIKI KAISHA (JP) | 2012-02-02 | — | — | WO | disclosed |
| US-20110237566-A1 | Therapeutic Macrolide Compounds and Their Use | MERLION PHARMACEUTICALS PTE LTD (SG) | 2011-09-29 | — | — | US | disclosed |
| US-20110237566-A1 | Therapeutic Macrolide Compounds and Their Use | MERLION PHARMACEUTICALS PTE LTD (SG) | 2011-09-29 | — | — | US | disclosed |
| WO-2010107739-A2 | METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2010-09-23 | — | — | WO | disclosed |
| WO-2010107742-A2 | METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2010-09-23 | — | — | WO | disclosed |
| WO-2009039246-A2 | METHODS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION, COMPOSITIONS FOR TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION, AND SCREENING ASSAYS FOR IDENTIFYING COMPOSITIONS FOR TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION | STANFORD UNIVERSITY (US) | 2009-03-26 | — | — | WO | disclosed |
| US-20090030039-A1 | Piperidine Derivatives as Cxcr3 Receptor Antagonists | JANSSEN PHARMACEUTICA, N.V. (BE) | 2009-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303562-A1 | PYRAZOLE COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF | CYP51A1, CYP4F11, WEE1 | PNMT 3998/4885GABRA1 1882/4885GABRB2 2786/4885 |
| US-20210047329-A1 | SUBSTITUTED 4,6-DIHYDROSPIRO[[1,2,3]TRIAZOLO[4,5-B]PYRIDINE-7,3'-INDOLINE]-2',5(3H)-DIONE ANALOGUES | DHPS, QDPR, HTR5A | PNMT 371/4885GABRA1 1450/4885GABRB2 1526/4885 |
| US-20190375792-A1 | Cyclic Peptide Antiviral Agents and Methods Using Same | VIP, CCL5, ZC3HAV1 | PNMT 4566/4885GABRA1 4510/4885GABRB2 4737/4885 |
| US-20180086767-A1 | WDR5 INHIBITORS AND MODULATORS | WDR5, WDR1, WDR77 | PNMT 3095/4885GABRA1 3160/4885GABRB2 3492/4885 |
| US-20190084988-A1 | WDR5 INHIBITORS AND MODULATORS | WDR5, WDR1, WDR3 | PNMT 3768/4885GABRA1 2682/4885GABRB2 2703/4885 |
| US-20090030039-A1 | Piperidine Derivatives as Cxcr3 Receptor Antagonists | CXCR3, CXCR1, CXCR2 | PNMT 2288/4885GABRA1 532/4885GABRB2 1159/4885 |
| US-20200190009-A1 | Antibiotic Compounds | CUTA, NRDC, CLPP | PNMT 4038/4885GABRA1 2738/4885GABRB2 2131/4885 |
| US-20220095614-A1 | Antibiotic Compounds | CUTA, NRDC, CLPP | PNMT 4038/4885GABRA1 2738/4885GABRB2 2131/4885 |
| US-20220204565-A1 | Cyclic Peptide Antiviral Agents and Methods Using Same | ZC3HAV1, VIP, LNPEP | PNMT 3782/4885GABRA1 4435/4885GABRB2 4443/4885 |
| US-20140256700-A1 | CARBAZOLE COMPOUNDS USEFUL AS BROMODOMAIN INHIBITORS | BRD3, BRD4, BRPF3 | PNMT 1089/4885GABRA1 1064/4885GABRB2 867/4885 |
| US-20110237566-A1 | Therapeutic Macrolide Compounds and Their Use | MALT1, HDAC6, BCL6 | PNMT 4371/4885GABRA1 4636/4885GABRB2 4509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.